Prescription-indication of proton pump inhibitors

Cost of inadequate prescription in a first level institution in Colombia

  • Melissa Hiromi Emura-Vélez Fundación Universitaria Autónoma de las Américas, Pereira, Colombia
  • Melissa Aguirre-Cardona Fundación Universitaria Autónoma de las Américas, Pereira, Colombia
  • Diana María Cardona-Echeverri Fundación Universitaria Autónoma de las Américas, Pereira, Colombia
  • Manuela Alejandra García-Maurno Fundación Universitaria Autónoma de las Américas, Pereira, Colombia
  • Diego Arturo García-Ospina Fundación Universitaria Autónoma de las Américas, Pereira, Colombia
  • Eliana Andrea Gutiérrez-Osorio Fundación Universitaria Autónoma de las Américas, Pereira, Colombia
  • Juan Daniel Castrillón-Spitia Fundación Universitaria Autónoma de las Américas, Pereira, Colombia

Abstract

Introduction: Proton Pump Inhibitors (PPIs) are anti-ulcer drugs that have presented patterns of use different from those authorized, which is why it was sought to determine the prescription indication of PPIs in a first-level institution in La Virginia, Risaralda as well as the cost of inadequate prescription. Design: prescription-indication study of medication. Methods: study of prescription-indication in patients older than 18 years with formulation of a PPI attended at the San Pedro and San Pablo Hospital of La Virginia, Risaralda, between July 1, 2016 and July 31, 2017. A proportional simple random sample was obtained. The clinical histories were used as a unit of analysis. Sociodemographic variables, comorbidities, prescription-indication patterns and polypharmacy were included. Adequate prescription-indication of PPI was defined according to the latest available scientific evidence. Epiinfo 7.2 was used to perform descriptive statistics, X2 and a binary logistic regression (P <0.05). For the cost analysis, reference cost per unit of IBP and DHD x 1000 inhabitants/day was defined. It had bioethical approval. Results: 317 patients were analyzed, of which 65.6% were women. Omeprazole was the most frequent PPI prescribed (93.7%). An inadequate prescription was presented in 46.3% of the patients, being the emergency service the one with the highest inadequate prescription presented (53.1%). The main diagnoses associated with the inappropriate indication of PPI were arterial hypertension (10%) followed by diabetes (6.0%). Seven variables were associated with a higher probability of presenting an adequate prescription of a PPI. The estimated annual cost for inadequate prescription of PPI was COP $446 602 606 DHD x1000 inhabitants/year. Conclusions: a high proportion of inadequate prescription of PPIs is described in the population of a first level of care, representing a high cost for the hospital center

Metrics

Metrics Loading ...

Author Biography

Juan Daniel Castrillón-Spitia, Fundación Universitaria Autónoma de las Américas, Pereira, Colombia
Especialista en Epidemiología, Grupo de Investigación Biomedicina
Published
2018-12-15
How to Cite
Emura-Vélez, M. H., Aguirre-Cardona, M., Cardona-Echeverri, D. M., García-Maurno, M. A., García-Ospina, D. A., Gutiérrez-Osorio, E. A., & Castrillón-Spitia, J. D. (2018). Prescription-indication of proton pump inhibitors: Cost of inadequate prescription in a first level institution in Colombia. Acta Medica Colombiana, 43(4), 183-191. https://doi.org/10.36104/amc.2018.1264
Section
Original works